widely used hq program accelerator merck global in brazil
HQ Program - Accelerator | Merck global
The HQ Accelerator Program is therefore complemented by a tailored program organized by the China Innovation hub team, where they can test their business model and develop localization strategies. Start your journey in the Merck headquarters in Darmstadt, Germany and take your chance at getting access to the Chinese market.
Send Inquiry
Startups - Innovation Center | Merck global
ATR is a cost effective and signal enhanced sample carrier for IR-spectroscopy used in blood testing. Ectica Technologies Hydrogel-based laboratory products with a 3D cell culture that closely emulate the human body , thereby allowing more reliable preclinical trials.
Send Inquiry
Ectica Technologies Wins Merck as a Customers - News
Besides all the HQ Accelerator program advantages, you can also get the chance to extend your stay in our China Innovation Hub Accelerator and gain access to the Chinese market. The seventh round of the Merck Accelerator Program starts in January 2019 and applications are open from 2 July to 30 September 2018.
Send Inquiry
Cubuslab: Piloting Digital Labs with Merck - News
Piloting with Merck. The startup’s technology is now tested by Merck as a pilot project. During the Accelerator, a collaboration started to play out very well product wise. Within their partnership with Merck, the Cubuslab team have had the opportunity to get their product development going within the various specialized laboratories at Merck.
Send Inquiry
FAQ - Innovation Center | Merck global
The HQ Accelerator Program will be hosted in the Merck Innovation Center in our headquarters in Darmstadt. All workspaces, meeting rooms, co-creation areas, Makerspace and communication technologies in our Innovation Center will be available to you during the program period.
Send Inquiry
Merck’s KEYTRUDA® (pembrolizumab) Continues to Show
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced updated results from the phase 3 KEYNOTE-045 trial evaluating KEYTRUDA® (pembrolizumab), the company’s anti-PD-1 therapy, in patients with locally advanced or metastatic urothelial carcinoma (a type of bladder cancer) with disea
Send InquiryMerck’s Investigational Beta-lactamase Inhibitor
Today's Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside of the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions.
Send Inquiry
Merck Statement on GARDASIL® | Merck Newsroom Home
Today's Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health ...
Send Inquiry
The MECTIZAN® Donation Program
To enable this collaboration, Merck established the Mectizan Donation Program (MDP), a ground-breaking public-private partnership. Operating from the Atlanta-based Task Force for Global Health, the MDP coordinates technical and operational activities between Merck, WHO, the World Bank, and a range of public and private stakeholders.
Send Inquiry
Merck.com | Homepage
For more than a century, Merck has been inventing medicines and vaccines for many of the world's most challenging diseases. We have always been and always will be inventing, and we do it for the single greatest purpose: Life.
Send Inquiry
HQ Program - Accelerator | Merck global
The HQ Accelerator Program is therefore complemented by a tailored program organized by the China Innovation hub team, where they can test their business model and develop localization strategies. Start your journey in the Merck headquarters in Darmstadt, Germany and take your chance at getting access to the Chinese market.
Send Inquiry
Startups - Innovation Center | Merck global
ATR is a cost effective and signal enhanced sample carrier for IR-spectroscopy used in blood testing. Ectica Technologies Hydrogel-based laboratory products with a 3D cell culture that closely emulate the human body , thereby allowing more reliable preclinical trials.
Send Inquiry
Ectica Technologies Wins Merck as a Customers - News
Besides all the HQ Accelerator program advantages, you can also get the chance to extend your stay in our China Innovation Hub Accelerator and gain access to the Chinese market. The seventh round of the Merck Accelerator Program starts in January 2019 and applications are open from 2 July to 30 September 2018.
Send Inquiry
FAQ - Innovation Center | Merck global
The HQ Accelerator Program will be hosted in the Merck Innovation Center in our headquarters in Darmstadt. All workspaces, meeting rooms, co-creation areas, Makerspace and communication technologies in our Innovation Center will be available to you during the program period.
Send Inquiry
Merck Accelerator Programme for Innovative African
About the Award: The program is run in collaboration with the Merck Accelerator in Darmstadt and there are plenty of opportunities for exchange. The Nairobi based program will be focussed on supporting companies addressing the big healthcare issues in Africa regardless of current location.
Send Inquiry
Merck Accelerator | Crunchbase
Merck Accelerator is a looking for real partners so that they can work together in shaping the future. With programs in their headquarters in Germany, in China and their Satellites events in Africa, startups can find their perfect fit and connect to their global network for collaboration.
Send Inquiry
Merck Accelerator – VC4A
Merck Accelerator is looking to collaborate with African Startups Merck Accelerator in partnership with the Tech Entrepreneurship Initiative “Make-IT in Africa” launched a Joint Startup Program to support 20 Startups across Africa.
Send Inquiry
Merck’s Investigational Beta-lactamase Inhibitor
Merck plans to initiate Phase 3 studies with relebactam in combination with imipenem/cilastatin in 2015. About Merck. Today's Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside of the United States and Canada.
Send Inquiry